Breaking News Instant updates and real-time market news.

PI

Impinj

$55.71

8.94 (19.11%)

, AMZN

Amazon.com

$987.71

23.54 (2.44%)

21:09
06/16/17
06/16
21:09
06/16/17
21:09

Impinj jumps after Amazon-Whole Foods announcement, Barron's says

Shares of Impinj (PI) surged during Friday trading after Amazon's (AMZN) announcement that it will acquire Whole Foods (WFM) for $13.7B due to a small connection between the RFID technology maker and Amazon, Barron's said. Impinj manufactures non-volatile-memory chips and radio frequency chips that are used in "tags" that can be attached to objects, and it also makes wireless scanning devices to read those tags at a distance, including for inventory management for groceries, the report pointed out. Barron's notes that Amazon is a member of "RAIN Alliance," a cooperative body that promotes RF tagging, though it is not yet clear if Amazon will utilize Impinj's technology. Reference Link

PI

Impinj

$55.71

8.94 (19.11%)

AMZN

Amazon.com

$987.71

23.54 (2.44%)

WFM

Bought by AMZN

$42.68

9.62 (29.10%)

  • 21

    Jun

PI Impinj
$55.71

8.94 (19.11%)

04/20/17
PACS
04/20/17
NO CHANGE
PACS
Impinj has significant growth opportunity, says Pacific Crest
Pacific Crest analyst Brad Erickson says that checks with U.S. retailers indicate that there is "plenty of opportunity" for increased RFID penetration in the retail market. The firm's checks indicate that Kohl's is only using RFID on 10%-20% of items. Checks also indicate that retail downsizing is creating only "relatively minimal headwinds" for RFID, added Erickson, He thinks that Street estimates for Impinj are "conservative," and he says that it can grow significantly. The analyst keeps a $40 price target and an Overweight rating on the stock.
05/05/17
PACS
05/05/17
NO CHANGE
PACS
Impinj should be bought on any weakness, says Pacific Crest
Pacific Crest analyst Brad Erickson says that the reiteration of Impinj's 2017 guidance could cause a decline in the stock, and he recommends buying the stock on any weakness. He is impressed with the company's new contract wins and he thinks that the guidance is conservative. The analyst keeps a $40 price target and an Overweight rating on the shares.
06/08/17
ADAM
06/08/17
NO CHANGE
Target $57
ADAM
Buy
Impinj price target raised to $57 from $38 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Impinj to $57 from $38 as he believes the company should post several years of 25% plus revenue growth, driven by strong adoption of the RAIN ecosystem in leading IoT vertical markets such as retail and healthcare. Walkley reiterated his Buy rating on Impinj shares.
06/13/17
PIPR
06/13/17
NO CHANGE
Target $50
PIPR
Overweight
Impinj price target raised to $50 from $36.50 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Impinj to $50 after spending time with CFO Evan Fein. The analyst believes the RAIN RFID market is progressing faster than previously anticipated with broad-based strength from new and existing customers. He raised his estimates to reflect 30% revenue growth through 2018 and keeps an Overweight rating on Impinj.
AMZN Amazon.com
$987.71

23.54 (2.44%)

06/16/17
PIPR
06/16/17
NO CHANGE
Target $1200
PIPR
Overweight
Piper reiterates $1,200 target on Amazon following Whole Foods deal
Piper Jaffray analyst Michael Olson believes the importance of Amazon's (AMZN) acquisition of Whole Foods (WFM) centers on the accelerations in its grocery strategy. Amazon's proximity to the U.S. consumer with grocery delivery range locations will increase from 20%-30% to near ubiquity, which "significantly" accelerates its grocery go-to-market, Olson tells investors in a research note titled "The Future of Grocery is Bright, Disruptive and Amazon's." Further, he believes Whole Foods' localized sourcing can "significantly improve" Amazon's grocery SKU quality. He reiterates an Overweight rating on Amazon with a $1,200 price target.
06/16/17
JEFF
06/16/17
NO CHANGE
Target $88
JEFF
Buy
Wal-Mart should be rallying on Whole Foods takeover, says Jefferies
Jefferies analyst Daniel Binder views the "knee-jerk" selloff in Wal-Mart (WMT) shares following Amazon's (AMZN) acquisition of Whole Foods (WFM) as overdone. The deal suggests having a store base in food "is important after all," Binder tells investors in a research note. Investors should be buying Wal-Mart today, not "taking it to the woodshed," the analyst argues. The company has roughly 4,500 points of distribution in food while Amazon just bought 461, Binder writes in a research note titled "Stores Are Important After All!." He recommends buying Wal-Mart on the weakness today and keeps a Buy rating on the name with an $88 price target. The retailing giant is down 5%, or $3.67, to $75.24 in afternoon trading.
06/16/17
BARD
06/16/17
NO CHANGE
BARD
Wal-Mart, Costco weakness on Amazon news a buying opportunity, says Baird
Baird analyst Peter Benedict said he we views Amazon's (AMZN) deal to buy Whole Foods (WFM) as reinforcing the value of local distribution and he believes Wal-Mart (WMT) and Costco (COST) are particularly well positioned to compete in the omni-channel grocery market. The analyst, who recommends using today's weakness in those two stocks as a buying opportunity, keeps an Outperform rating on both, while maintaining a Neutral rating on Target (TGT), noting that he thinks today's news "raises the bar" on its need to find an effective strategy to turn its grocery business.
06/16/17
06/16/17
DOWNGRADE

Neutral
Costco downgraded to Neutral from Conviction Buy at Goldman Sachs
As previously reported, Goldman downgraded Costco (COST) to Neutral from Conviction Buy and lowered its price target to $176 from $197. Analyst Matthew Fassler believes Costco's valuation will be capped due to Amazon's (AMZN) ongoing moves into consumables, online investments by Wal-Mart (WMT) and fading fundamental catalysts. He believes Amazon will offer superior pricing and delivery competency versus incumbents but does not anticipate meaningful erosion in warehouse business trends any time soon.
WFM Bought by AMZN
$42.68

9.62 (29.10%)

06/16/17
LEHM
06/16/17
UPGRADE
Target $48
LEHM
Overweight
Barclays upgrades Whole Foods on potential for bidding war
As previously reported, Barclays analyst Karen Short upgraded Whole Foods (WFM) to Overweight from Equal Weight and raised her price target on the stock to $48 from $38, telling investors that she would not be surprised to see a bidding war break out following Amazon's (AMZN) announcement of a takeover agreement. Short, who thinks a strategic retail buyer would generate up to $600M in synergies from a deal to buy Whole Foods, said bidders could include Kroger (KR), Target (TGT), and Wal-Mart (WMT), all of which may "have too much to lose not to bid."

TODAY'S FREE FLY STORIES

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

, AXAHY

AXA

$29.47

0.13 (0.44%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Periodicals
BNP weighing tie-up of money-management division with Axa unit, Bloomberg says »

BNP Paribas (BNPQY),…

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

AXAHY

AXA

$29.47

0.13 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHFC

Chemical Financial

$49.32

0.71 (1.46%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Downgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSII

Quality Systems

$15.71

-0.14 (-0.88%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Initiation
Quality Systems initiated  »

Quality Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
09/19/17
09/19
07:45
09/19/17
07:45
General news
N.Y. FX Outlook »

N.Y. FX Outlook: Risk-on…

HOLI

Hollysys

$20.77

0.42 (2.06%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Conference/Events
Hollysys management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 16

    Oct

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

KORS

Michael Kors

$44.65

-0.27 (-0.60%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Technical Analysis
Technical View: Michael Kors moves higher, analyst action »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Periodicals
Intel Capital invested over $1B in AI-focused companies, TechCrunch says »

Intel has invested more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 05

    Oct

PDCO

Patterson Companies

$37.94

-0.59 (-1.53%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Initiation
Patterson Companies initiated  »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$179.98

3.28 (1.86%)

, BSTI

BEST Inc

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Syndicate
BEST Inc cuts size of proposed IPO following 'tepid' response, Reuters reports »

Best Inc (BSTI), a…

BABA

Alibaba

$179.98

3.28 (1.86%)

BSTI

BEST Inc

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FOLD

Amicus

$13.67

-0.21 (-1.51%)

07:42
09/19/17
09/19
07:42
09/19/17
07:42
Hot Stocks
Amicus granted FDA Fast Track Designation for migalastat »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.73

0.1 (3.80%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Initiation
Rite Aid initiated  »

Rite Aid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Periodicals
Portola blood thinner launch could be complicated by guidelines, STAT News says »

The commercial launch of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

CRL

Charles River

$107.29

1.27 (1.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Hot Stocks
Post Holdings to acquire Bob Evans for $77.00 per share »

Post Holdings (POST) and…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.01

-1.63 (-0.95%)

, AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Periodicals
FB design head touts voice command, stays silent on hardware, TechCrunch says »

Facebook (FB) head of…

FB

Facebook

$170.01

-1.63 (-0.95%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.